Text Size

Glycaemic Response Testing

This study has been completed.
Sponsor:
Collaborator:
Reading Scientific Services Ltd.
Information provided by (Responsible Party):
Mondelēz International, Inc.
ClinicalTrials.gov Identifier:
NCT01536847
First received: February 16, 2012
Last updated: September 7, 2012
Last verified: September 2012
History of Changes
  Purpose

The purpose of this study is to assess whether added food ingredient(s) affect glycemic responses to a liquid meal tolerance test (LMTT).


Condition Intervention
Glycaemic Index
Glycaemic Response
 Other: Dietary Intervention

Study Type: Interventional
Study Design: Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Single Blind (Subject)
Primary Purpose: Basic Science
Official Title: Glycaemic Response Testing

Further study details as provided by Mondelēz International, Inc.:

Primary Outcome Measures:
  • Glycaemic index of experimental test food using capillary blood [ Time Frame: 0-120 minutes ] [ Designated as safety issue: No ]

Enrollment: 12
Study Start Date: December 2011
Study Completion Date: January 2012
Primary Completion Date: January 2012 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Placebo Comparator: Control Test Drink
Control drink
 Other: Dietary Intervention
300 ml of liquid food product
Experimental: Experimental Test Drink 1
Control drink containing ingredient 1
 Other: Dietary Intervention
300 mL of liquid food product
Experimental: Experimental Test Drink 2
Control drink containing ingredient 2
 Other: Dietary Intervention
300 ml of liquid food product

  Eligibility

Ages Eligible for Study:   18 Years to 55 Years
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male or female (not less than 40% males or females
  • Non-smoker
  • Aged 18 to 55 years
  • Have a body mass index between 18.5 to 29.99 kg/m2
  • Healthy, non-diabetic, no gastric bypass surgery
  • Having a fasting plasma glucose (finger stick) <100 mg/dl (<5.5 mmol/L)
  • Willing and able to provide written informed consent
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT01536847

Sponsors and Collaborators
Mondelēz International, Inc.
Reading Scientific Services Ltd.
Investigators
Principal Investigator: Suzana Louth, Dr RSSL
  More Information

No publications provided

Responsible Party: Mondelēz International, Inc.
ClinicalTrials.gov Identifier: NCT01536847     History of Changes
Other Study ID Numbers: P11-09257
Study First Received: February 16, 2012
Last Updated: September 7, 2012
Health Authority: United Kingdom: Research Ethics Committee

ClinicalTrials.gov processed this record on May 19, 2013